1. Home
  2. ATEN vs DYN Comparison

ATEN vs DYN Comparison

Compare ATEN & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATEN
  • DYN
  • Stock Information
  • Founded
  • ATEN 2004
  • DYN 1984
  • Country
  • ATEN United States
  • DYN United States
  • Employees
  • ATEN N/A
  • DYN N/A
  • Industry
  • ATEN EDP Services
  • DYN Medicinal Chemicals and Botanical Products
  • Sector
  • ATEN Technology
  • DYN Health Care
  • Exchange
  • ATEN Nasdaq
  • DYN Nasdaq
  • Market Cap
  • ATEN 1.3B
  • DYN 1.4B
  • IPO Year
  • ATEN 2014
  • DYN 2020
  • Fundamental
  • Price
  • ATEN $19.15
  • DYN $9.57
  • Analyst Decision
  • ATEN Strong Buy
  • DYN Strong Buy
  • Analyst Count
  • ATEN 3
  • DYN 15
  • Target Price
  • ATEN $21.33
  • DYN $43.60
  • AVG Volume (30 Days)
  • ATEN 705.3K
  • DYN 2.7M
  • Earning Date
  • ATEN 07-29-2025
  • DYN 08-11-2025
  • Dividend Yield
  • ATEN 1.25%
  • DYN N/A
  • EPS Growth
  • ATEN 9.85
  • DYN N/A
  • EPS
  • ATEN 0.67
  • DYN N/A
  • Revenue
  • ATEN $267,158,000.00
  • DYN N/A
  • Revenue This Year
  • ATEN $9.40
  • DYN N/A
  • Revenue Next Year
  • ATEN $7.66
  • DYN N/A
  • P/E Ratio
  • ATEN $28.60
  • DYN N/A
  • Revenue Growth
  • ATEN 4.90
  • DYN N/A
  • 52 Week Low
  • ATEN $12.27
  • DYN $6.36
  • 52 Week High
  • ATEN $21.90
  • DYN $47.45
  • Technical
  • Relative Strength Index (RSI)
  • ATEN 68.23
  • DYN 32.17
  • Support Level
  • ATEN $17.54
  • DYN $10.00
  • Resistance Level
  • ATEN $19.31
  • DYN $10.74
  • Average True Range (ATR)
  • ATEN 0.44
  • DYN 0.88
  • MACD
  • ATEN 0.08
  • DYN -0.48
  • Stochastic Oscillator
  • ATEN 84.18
  • DYN 0.53

About ATEN A10 Networks Inc.

A10 Networks Inc is a provider of security and infrastructure solutions for on-premises, hybrid cloud, and edge-cloud environments of its multinational enterprise, communication, cloud and web service provider customers who strive to provide business-critical applications and networks that are secure, available, and efficient. As cyber-attacks increase in volume and complexity, the company integrates security and artificial intelligence (AI) enabled capabilities in its solutions that enable its customers to continue to adapt to market trends in hybrid cloud, AI-ready data centers and the ever-increasing need for high-performance, high availability and low latency. The company generates the maximum of its revenue from Americas.

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

Share on Social Networks: